AIX 9.01 ▲0.33% ALU 0.88 ▼-2.22% DN1 99.70 ▼-0.09% EMUCA 0.89 KIT 1.90 ▲0.00% KKC 2.11 ▲0.00% LF1 1.92 ▲0.79% MBG 0.14 ▲0.00% MRE 1.88 ▼-0.53% PCI 1.09 ▼-0.91% PCX 1.99 ▼-0.75% RF1 3.52 ▼-0.28% SET 2.14 ▼-0.47% BST 0.30 ▲3.45% CTS 0.56 ▲1.82% EFR 0.00 ▲0.00% FDC 3.33 ▼-1.19% KOA 3.10 ▲1.64% AIX 9.01 ▲0.33% ALU 0.88 ▼-2.22% DN1 99.70 ▼-0.09% EMUCA 0.89 KIT 1.90 ▲0.00% KKC 2.11 ▲0.00% LF1 1.92 ▲0.79% MBG 0.14 ▲0.00% MRE 1.88 ▼-0.53% PCI 1.09 ▼-0.91% PCX 1.99 ▼-0.75% RF1 3.52 ▼-0.28% SET 2.14 ▼-0.47% BST 0.30 ▲3.45% CTS 0.56 ▲1.82% EFR 0.00 ▲0.00% FDC 3.33 ▼-1.19% KOA 3.10 ▲1.64%

BGT Bio-Gene Technology Limited

Healthcare · Biotechnology · website
$0.02
52wk 0.02 – 0.06
Overall
Value
Growth
Health
Quality
Momentum
Dividend
Price
About Bio-Gene Technology Limited

Bio-Gene Technology Limited, an agtech development company, engages in the development and commercialization of naturally derived insecticide products in Australia and internationally. Its products include Flavocide, a synthetically produced nature-identical compound; and Qcide, a natural plant-derived oil with high levels of tasmanone. The company has a research collaboration agreement with James Cook University for experiments demonstrating the value of pre-conditioning biomass prior to distillation; Cesar for assessing the insecticidal activity of its molecules against a range of insect species; Advanced Molecular Technologies; CSIRO for a chemistry development process; the Department of Agriculture and Fisheries, Queensland Government for assessing activity against grain storage pests; Eurofins; Grain Research Development Corporation; Pacific Discovery Services; Purdue University; Southern Cross University for chemical analysis of natural products; University of Florida; and University of Technology. It serves animal health, crop protection, grain storage, public health, and consumer applications, as well as insect management in crop protection. The company was incorporated in 1995 and is based in Melbourne, Australia.

Fundamental trends
Financial statements
Loading…
Key metrics
Market cap
$8.88M
P/E (trailing)
P/E (forward)
EPS (trailing)
-0.01
Dividend yield
Payout ratio
0.0%
Beta
0.78
EV / EBITDA
-2.38
Price / Book
5.75
ROE
-202.2%
Operating margin
-304.2%
Net margin
0.0%
Total cash
$1.08M
Total debt
$0
Current ratio
4.31
Debt / Equity
Free cash flow
$-1.64M
Avg volume
454,537
Latest annual results (FY ending 30 Jun 2025)
  • Revenue
  • Gross profit
  • Operating income-$3.11M
  • Net income-$2.58M
  • Diluted EPS-0.01
  • Free cash flow-$2.54M
  • Net debt-$1.14M
Sector peers (Healthcare)
TickerMkt cap P/EScore
CSL $59.53B 14.0
RMD $43.89B 20.4
SIG $34.28B 59.4
FPH $20.25B 52.2
PME $17.21B 73.5
SHL $10.79B 19.7
RHC $10.13B 34.8
COH $7.90B 22.9